cladribine has been researched along with Allergic Encephalomyelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, S; Budde, T; Cerina, M; Dobelmann, V; Duarte-Silva, E; Fazio, L; Gothan, KSS; Gruchot, J; Henes, A; Herrmann, AM; Hundehege, P; Huntemann, N; Kremer, D; Küry, P; Meuth, SG; Müntefering, T; Narayanan, V; Nelke, C; Pfeuffer, S; Raba, K; Räuber, S; Rolfes, L; Ruck, T; Schroeter, CB; Wiendl, H | 1 |
| Centonze, D; Fresegna, D; Gentile, A; Haji, N; Mandolesi, G; Matarese, G; Motta, C; Musella, A; Paolillo, A; Rossi, S; Sepman, H; Studer, V | 1 |
| Fontoura, P; Garren, H | 1 |
1 review(s) available for cladribine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Multiple sclerosis therapies: molecular mechanisms and future.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Crotonates; Daclizumab; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Mice; Multiple Sclerosis; Myelin Basic Protein; Nitriles; Peptide Fragments; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Vaccines, DNA | 2010 |
2 other study(ies) available for cladribine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis.
Topics: Animals; Cladribine; Disease Models, Animal; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Neuroprotective Agents | 2022 |
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
Topics: Animals; Cell Proliferation; Cerebral Cortex; Chelating Agents; Cladribine; Corpus Striatum; Disease Models, Animal; Drug Delivery Systems; Egtazic Acid; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Glial Fibrillary Acidic Protein; Glutamic Acid; Immunosuppressive Agents; In Vitro Techniques; Interleukin-1beta; Mice; Mice, Inbred C57BL; Neuroglia; Patch-Clamp Techniques; Synapses | 2013 |